Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-06
DOI
10.1038/s41598-019-47814-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor
- (2018) KyeongJin Kim et al. Cell Metabolism
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo
- (2017) Lili Gu et al. Oncotarget
- PCSK9 inhibitors for hypercholesterolaemia
- (2017) Patricia McGettigan et al. BMJ-British Medical Journal
- PCSK9 inhibitors for hypercholesterolaemia
- (2017) Patricia McGettigan et al. BMJ-British Medical Journal
- New Therapeutic Approaches to the Treatment of Dyslipidemia
- (2016) Daniel J. Rader Cell Metabolism
- Mammalian tolloid proteinases: role in growth factor signalling
- (2016) Helen Troilo et al. FEBS LETTERS
- Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci
- (2016) Clint L. Miller et al. Nature Communications
- Diversity between mammalian tolloid proteinases: Oligomerisation and non-catalytic domains influence activity and specificity
- (2016) Christopher P. Bayley et al. Scientific Reports
- Statin intolerance
- (2015) Ulrich Laufs et al. CURRENT OPINION IN LIPIDOLOGY
- The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
- (2014) Cynthia Hong et al. Cell Metabolism
- Reducing Elevated Plasma LDL Cholesterol: The Central Role of the LDL Receptor
- (2014) J Vincent CLINICAL PHARMACOLOGY & THERAPEUTICS
- Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells
- (2014) Mi-Hsueh Tai et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Procollagen C-proteinase enhancer grasps the stalk of the C-propeptide trimer to boost collagen precursor maturation
- (2013) J.-M. Bourhis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH
- (2011) Paola Lo Surdo et al. EMBO REPORTS
- Characterization of a naturally occurring degradation product of the LDL receptor
- (2011) Kristian Tveten et al. MOLECULAR GENETICS AND METABOLISM
- Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1
- (2009) Jian Zhu et al. JOURNAL OF LIPID RESEARCH
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
- (2009) Noam Zelcer et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation